BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7696314)

  • 21. Glycosylation at Asn-184 inhibits the conversion of single-chain to two-chain tissue-type plasminogen activator by plasmin.
    Wittwer AJ; Howard SC
    Biochemistry; 1990 May; 29(17):4175-80. PubMed ID: 2141793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement of zymogen modification for activation of porcine plasminogen.
    Machovich R; Litwiller RD; Owen WG
    Biochemistry; 1992 Nov; 31(46):11558-61. PubMed ID: 1445889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate.
    Kulisek ES; Holm SE; Johnston KH
    Anal Biochem; 1989 Feb; 177(1):78-84. PubMed ID: 2525884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
    Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
    J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage.
    Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E
    Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myosin as cofactor and substrate in fibrinolysis.
    Machovich R; Ajtai K; Kolev K; Owen WG
    FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis.
    Bergum PW; Gardell SJ
    J Biol Chem; 1992 Sep; 267(25):17726-31. PubMed ID: 1387641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.
    Lind SE; McDonagh JR; Smith CJ
    Blood; 1993 Sep; 82(5):1522-31. PubMed ID: 8364203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC; Suenson E
    Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
    Chmielewska J; RĂ„nby M; Wiman B
    Biochem J; 1988 Apr; 251(2):327-32. PubMed ID: 3135797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of plasmin activity by oleic acid.
    Higazi AA; Finci-Yeheskel Z; Samara AA; Aziza R; Mayer M
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):863-6. PubMed ID: 1532491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
    Urano T; deSerrano VS; Urano S; Castellino FJ
    Arch Biochem Biophys; 1989 Apr; 270(1):356-62. PubMed ID: 2494944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V; Pannell R; Broeze RJ; Mao J
    J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
    Karlan BY; Clark AS; Littlefield BA
    Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of plasmin activity by aspirin.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Thromb Haemost; 1991 Apr; 65(4):389-93. PubMed ID: 1829277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).
    Pannell R; Gurewich V
    Blood; 1987 Jan; 69(1):22-6. PubMed ID: 3790724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of fibrinolytic system by liquoid (polyanetholesulfonate). A contributing factor in the liquoid-induced renal cortical necrosis.
    Gilboa N; Ryan TJ; MacColl R
    Haemostasis; 1987; 17(3):162-70. PubMed ID: 3038710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.